论文信息 - RELAY+: Exploratory study of ramucirumab plus gefitinib in untreated patients (pts) with epidermal growth factor receptor (EGFR)-mutated metastatic non-small cell lung cancer (NSCLC). - 字舞流文

RELAY+: Exploratory study of ramucirumab plus gefitinib in untreated patients (pts) with epidermal growth factor receptor (EGFR)-mutated metastatic non-small cell lung cancer (NSCLC).

K. Nishio | S. Ikeda | A. Zimmermann | M. Nishio | K. Hirano | M. Reck | K. Nakagawa | E. Garon | F. Imamura | T. Kawaguchi | C. Visseren-Grul | R. Widau | Gosuke Homma | H. Yamaguchi | S. Enatsu